ADVANCE infectious diseases pharmacy through collaboration, research and education and LEAD antimicrobial stewardship to OPTIMIZE the care of patients with infections in every practice setting

Forgot password
  • Home
  • About
  • News
  • FDA approves peramavir (Rapivab) for acute uncomplicated influenza

FDA approves peramavir (Rapivab) for acute uncomplicated influenza

07 Jan 2015 5:43 PM | Kristi Kuper
BioCryst's RAPIVAB(TM) (peramivir injection) Receives FDA Approval for the Treatment of Acute Uncomplicated Influenza. See http://rapivab.com/prescribing-information/



Society of Infectious Diseases Pharmacists •  PO Box 1488, Warrenville, IL 60555
(331) 248-7888 • sidp@affinity-strategies.com
Proudly Managed by Affinity Strategies

Powered by Wild Apricot Membership Software